Emcure Pharmaceuticals Limited — JV/Acquisition, 03-10-2025: Acquisition

Emcure Pharmaceuticals has completed the acquisition of the remaining 20.42% stake in its pharmaceutical subsidiary, Zuventus Healthcare Limited, for ₹724.9 Cr. This transaction elevates Zuventus to a wholly-owned subsidiary status, consolidating Emcure's control over this key asset. Zuventus reported a FY25 turnover of ₹1,079.9 Cr and a PAT of ₹134.8 Cr. This strategic move is expected to streamline operations and enhance integration within Emcure's core pharma business, ensuring full strategic alignment.